Tag: Phase
-
Pfizer's Phase III renal cell carcinoma trial fails to meet primary endpoint
Pfizer's Phase III renal cell carcinoma trial fails to meet major endpoint The mixture of bevacizumab and IFN-alpha-2a is authorized as first-line treatment for advanced RCC and clinical supplies of both of these drugs in this trial were provided through an agreement with Roche. … The inhibition of mTOR also reduces … Study far more…
-
Phase I Cancer Clinical Trials: A Practical Guide
Phase I trials are a vital initial step in the study of novel therapeutic approaches. They stick to years of development in the laboratory, and precede Phase II and III trials where testing of the drug becomes far more focused yet is conducted on a wider scale. The major targets of Phase I trials are…